Targeted gene disruption on complex genetic backgrounds. Robust engraftment of human hepatocytes in novel xenorecipient strain. Persistent HBV viremia in human liver chimeric mice. Viral suppression upon HBV treatment. Potential utility for anti-HBV drug testing.